Pro zobrazení tohoto obsahu je třeba být přihlášen.
Author Archives for m.popovic@wemakemedia.cz
Efficacy of the Addition of Cisplatin to Single-Agent First-Line Chemotherapy in Elderly Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Joint Analysis of the Multicenter, Randomized Phase III MILES-3 and MILES-4 studies
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Metastatic Abstract number: 9002 Citation: J...
Alectinib Versus Crizotinib in Treatment-Naive Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC): Primary Results of the Global Phase III ALEX Study
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Metastatic Abstract number: LBA 9008 Citation:...
First-line carboplatin and pemetrexed (CP) with or without pembrolizumab (pembro) for advanced nonsquamous NSCLC: Updated results of KEYNOTE-021 cohort G
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Metastatic Abstract number: 9094 Citation: J...
Nivolumab (N) plus ipilimumab (I) as first-line (1L) treatment for advanced (adv) NSCLC: 2-yr OS and long-term outcomes from CheckMate 012
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Metastatic Abstract number: 9093 Citation: J...
Response to salvage chemotherapy following exposure to immune checkpoint inhibitors in patients with non-small cell lung cancer
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Metastatic Abstract number: 9084 Citation: J...
Efficacy, safety, and biomarker results of trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-overexpressing locally advanced or metastatic non-small cell lung cancer (mNSCLC)
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Metastatic Abstract number: 8509 Citation: J...
Education Session Reviews Current Management of Early-Stage NSCLC, Offers Glimpse of Future Advances
29 septembra, 2020 8:31 pm Leave your thoughtsJune 3, 2017 Approximately 15% of all patients with non–small cell lung cancer (NSCLC) present with disease in early...
KARCINÓM PĽÚC NA ASCO 2017
29 septembra, 2020 8:31 pm Leave your thoughtsÚvod Konferencia ASCO 2017 (v ďalšom texte iba ASCO) priniesla tento rok v oblasti karcinómu pľúc celý rad nových poznatkov a pre mňa...
A randomized phase II cross-over study of abiraterone + prednisone (ABI) vs enzalutamide (ENZ) for patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC)
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Genitourinary (Prostate) Cancer Abstract number: 5002 Citation: J Clin Oncol 35,...
Biomarker findings and mature clinical results from KEYNOTE-052: First-line pembrolizumab (pembro) in cisplatin-ineligible advanced urothelial cancer (UC)
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Genitourinary (Nonprostate) Cancer Abstract number: 5502 Citation: J Clin Oncol 35,...